Intel
INTC
$89.85
-5.79%
Intel is a leading digital chipmaker that designs and manufactures microprocessors for the global personal computer and data center markets, and it pioneered the x86 architecture that underpins much of the semiconductor industry; today it operates through client computing (CCPG), data center and AI (DCAI), and its Intel Foundry manufacturing arm. Historically the volume leader in PC and server CPUs, Intel is now repositioning itself as a vertically integrated foundry player attempting to reclaim process leadership with its 18A node, a strategy that makes it distinct from fabless rivals and from pure-play foundry TSMC. The investor narrative has swung violently: a 170%+ year-to-date rally has been fueled by optimism around the foundry turnaround, 18A ramp, and a booming data center business, but recent headlines—including Elon Musk's suggestion that TSMC could join the Terafab partnership, undermining a key foundry catalyst—have reignited debate over whether the turnaround is real or overpriced. With the stock down roughly 37% from its 52-week high in just weeks, investors are now forced to weigh genuine revenue acceleration and margin recovery against a still-unprofitable income statement and a valuation that prices in a lot of execution.…
INTC
Intel
$89.85
Related headlines
Investment Opinion: Should I buy INTC Today?
Rating: Hold. The core thesis is that Intel's revenue acceleration (+25.4% YoY) and gross margin recovery (41.5%) are real, but the stock at $89.85 already discounts much of the turnaround, leaving a risk/reward that is balanced rather than compelling; the analyst consensus buy (mean 2.47) and average target of $118.05 imply 31.4% upside, but the path is highly volatile with a beta of 2.23.
Supporting evidence: revenue grew 25.4% YoY in Q2 2026, gross margin expanded from 27.5% to 41.5% over the same period, free cash flow TTM is positive at $2.83B, and the stock trades at 3.33x P/S and 14.5x EV/EBITDA, which is not extreme for a semiconductor turnaround but is rich versus Intel's own history. The forward PE of 42.7x and PEG of 6.23 are the key valuation concerns, as they price in significant earnings recovery that has not yet appeared (trailing EPS -$0.0015).
Risks and conditions: the biggest risks are a delay in 18A yields, loss of the Terafab catalyst to TSMC, and a broader AI chip selloff that compresses the 42.7x forward multiple. This Hold would upgrade to Buy if the stock pulls back toward the $80 analyst low (roughly -11%) while revenue growth holds above 20% and gross margin stays above 40%, or if forward EPS estimates rise enough to bring the forward PE below 30x. It would downgrade to Sell if revenue growth decelerates below 15% or if gross margin falls back below 35%. Valuation verdict: fairly valued to slightly overvalued relative to history and peers, given the unproven earnings recovery.
Sign up to view all
INTC 12-Month Price Forecast
The forward view is balanced: the company is delivering genuine top-line acceleration and margin recovery, but the valuation already embeds a successful 18A and foundry outcome, leaving limited margin of safety. The analyst consensus buy and $118 average target provide a positive anchor, but the recent 36.9% drawdown from the 52-week high and the Terafab catalyst risk argue for caution. I would upgrade to bullish if the company reports positive net income and confirms Terafab exclusivity, and downgrade to bearish if gross margin falls below 35% or forward EPS estimates are cut below $5.00.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Intel's 12-month outlook, with a consensus price target around $118.05 and implied upside of +31.4% versus the current price.
Average Target
$118.05
0 analysts
Implied Upside
+31.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$80 - $200
Analyst target range
Drowning in data?
Find the real signal!
Bulls vs Bears: INTC Investment Factors
The bull case rests on genuine revenue acceleration (+25.4% YoY), a dramatic gross margin recovery to 41.5%, and a consensus buy rating with 31% upside to the $118 average target. The bear case counters that the company is still unprofitable (EPS -$0.0015, net margin -0.51%), trades at 42.7x forward earnings with a 6.23 PEG, and faces a potential loss of the Terafab catalyst as TSMC may join. On balance, the bear evidence currently has the stronger near-term weight because the valuation already discounts a successful turnaround while the income statement has not yet delivered positive earnings. The single most important tension is whether the 18A ramp and foundry customer wins can convert revenue growth into sustainable positive net income before the 42.7x forward multiple compresses; resolution of that question will determine whether the stock re-rates toward $118 or retests the $80 analyst low.
Bullish
- Revenue growth accelerating sharply: Q2 2026 revenue of $16.13B grew 25.4% year-over-year, a marked acceleration from the prior quarters and evidence that the data center and 18A product ramp is translating into top-line momentum. This is the strongest growth rate in the provided quarterly series, which supports the turnaround narrative.
- Gross margin recovery underway: Gross margin expanded to 41.5% in Q2 2026 from 27.5% in Q2 2025 and 15.0% in Q3 2024, a dramatic improvement that signals pricing power and better factory utilization. The sequential climb from 39.4% in Q1 2026 to 41.5% in Q2 2026 shows the recovery is still gaining traction.
- Analyst consensus buy with 31% upside: 43 analysts rate the stock a buy (mean recommendation 2.47) with an average target price of $118.05, implying 31.4% upside from the current $89.85. The high target of $200 suggests substantial optionality if the foundry turnaround succeeds.
- Strong balance sheet and liquidity: Debt-to-equity is a manageable 0.41 and the current ratio is 2.02, indicating ample short-term liquidity to fund the capital-intensive 18A ramp. Free cash flow TTM is positive at $2.83B despite heavy capex, showing the business can self-fund part of its transition.
Bearish
- Still unprofitable with negative EPS: Trailing EPS is -$0.0015 and net margin is -0.51%, with Q2 2026 net income of -$11.03B driven by a $12.8B other expense line. The income statement remains deeply unprofitable, and the trailing PE is meaningless at -614.6, meaning valuation rests entirely on forward expectations.
- Extreme valuation on forward earnings: Forward PE is 42.7x and PEG is 6.23, both rich for a company with negative trailing earnings and a 34.8% gross margin. EV/EBITDA of 14.5x and P/S of 3.33x price in a successful turnaround that has yet to be proven.
- Terafab catalyst at risk: Recent news that Elon Musk confirmed TSMC could join the Terafab partnership undermines a key foundry catalyst for Intel, as reported by The Motley Fool on 2026-10-08. Losing exclusivity on a marquee foundry customer would weaken the 18A demand story that underpins the bull case.
- Severe drawdown and high volatility: The stock is down 36.9% from its 52-week high of $142.35 and has a beta of 2.23, meaning it amplifies market moves. Max drawdown over the period was -41.9%, and the 1-month change is -11.1% versus the S&P 500's +1.2%, showing sharp recent underperformance.
INTC Technical Analysis
Beta
2.23
2.23x market volatility
Max Drawdown
-41.9%
Largest decline past year
52-Week Range
$33-$142
Price range past year
Annual Return
+143.9%
Cumulative gain past year
| Period | INTC Return | S&P 500 |
|---|---|---|
| 1m | -11.1% | +0.2% |
| 3m | -5.5% | +2.9% |
| 6m | +31.2% | +8.4% |
| 1y | +143.9% | +14.9% |
| ytd | +128.2% | +11.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
INTC Fundamental Analysis
Quarterly Revenue
$16.1B
2026-06
Revenue YoY Growth
+25.4%
YoY Comparison
Gross Margin
41.5%
Latest Quarter
Free Cash Flow
$2.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is INTC Overvalued?
PE
-614.6x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 6x~26x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
14.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are substantial. The company reported a Q2 2026 net loss of $11.03B and EPS of -$2.16, driven by a $12.8B other expense line, and trailing net margin is -0.51%. Gross margin of 34.8% remains far below the 55-60% historical norm, and operating margin is -4.2%, meaning the core business is not yet generating operating profit. Free cash flow TTM is positive at $2.83B, but this is thin relative to the capital intensity of the 18A ramp, and debt-to-equity of 0.41, while manageable, leaves limited room for error if the foundry buildout requires additional funding.
Market and competitive risks are elevated. The stock trades at 42.7x forward earnings and 6.23x PEG, a premium that assumes a successful turnaround; any disappointment in 18A yields or foundry customer wins could trigger sharp multiple compression. Beta of 2.23 means the stock is more than twice as volatile as the market, and the 1-month relative strength of -12.3 percentage points versus the S&P 500 shows how quickly sentiment can reverse. Competitive threats include TSMC's potential entry into the Terafab partnership, which would dilute Intel's foundry catalyst, and Microsoft's Maia 300 AI chip, which could pressure the broader AI chip pricing environment.
Worst-case scenario: a combination of 18A yield delays, loss of the Terafab exclusivity to TSMC, and a broader semiconductor selloff could drive the stock toward its 52-week low of $32.89 or the analyst low target of $80. From the current $89.85, a move to the $80 analyst low represents a -11.0% loss, while a retest of the 52-week low would be a -63.4% loss. The historical max drawdown of -41.9% suggests a realistic severe downside of roughly -42% to about $52, consistent with a scenario where forward EPS estimates are cut and the multiple compresses toward 25x.
FAQ
The most severe risk is execution on the 18A node: any yield delay would undermine the foundry thesis and could cut forward EPS estimates, making the 42.7x forward PE untenable. Second is the Terafab catalyst risk, as Elon Musk has confirmed TSMC could join the partnership, which would reduce Intel's exclusive foundry opportunity. Third is financial risk: the company reported a Q2 2026 net loss of $11.03B and has a -0.51% net margin, so it remains unprofitable and dependent on continued revenue growth. Fourth is market risk: beta of 2.23 and a max drawdown of -41.9% mean the stock can fall sharply in a semiconductor selloff, as shown by the -11.1% one-month decline versus the S&P 500's +1.2%.
The 12-month forecast has three scenarios: a base case (50% probability) targeting $100-$118, aligned with the analyst average of $118.05, assuming revenue growth holds above 20% and gross margin stays around 40-42%; a bull case (25% probability) targeting $142-$200, requiring 18A success and Terafab confirmation; and a bear case (25% probability) targeting $80-$90, aligned with the analyst low of $80, if yields slip or TSMC joins Terafab. The most likely outcome is the base case, with the key assumption being that net income approaches breakeven by late 2026 and forward EPS of $6.57 is de-risked.
INTC appears fairly valued to slightly overvalued on forward metrics. The forward PE of 42.7x is rich for a company with negative trailing EPS (-$0.0015) and a 34.8% gross margin, and the PEG of 6.23 signals that the growth rate does not justify the multiple. On the other hand, P/S of 3.33x and EV/EBITDA of 14.5x are not extreme for a semiconductor turnaround, and the stock is 36.9% below its 52-week high of $142.35. The market is pricing in a successful 18A ramp and foundry customer wins; if those materialize, the valuation could be justified, but if they slip, the multiple has room to compress toward 25-30x forward earnings.
From a risk/reward perspective, INTC is a moderate buy only for risk-tolerant investors. The stock trades at $89.85, 31.4% below the analyst average target of $118.05, and the consensus rating is buy (mean 2.47), which suggests upside if execution continues. However, the forward PE of 42.7x and PEG of 6.23 leave little room for error, and the biggest downside risk is a retest of the $80 analyst low (-11%) or the 52-week low of $32.89 (-63%) if the 18A ramp stalls. It is a good buy for long-term investors who believe in the foundry turnaround and can tolerate a beta of 2.23, but it is not a low-risk entry at current levels.
INTC is better suited for long-term investment (minimum 2-3 years) than short-term trading. The turnaround is a multi-year process: the 18A ramp, foundry customer wins, and margin recovery will take several quarters to play out, and the stock's beta of 2.23 and max drawdown of -41.9% make short-term price action highly unpredictable. The company pays no dividend (yield 0%), so there is no income component to support a short-term hold. A long-term investor can look through the current unprofitability (EPS -$0.0015) toward the $6.57 forward EPS estimate, but should size positions to withstand a potential 40% drawdown.